[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"grant-kwf-cdd-scouting-programme-2026":3,"similar-kwf-cdd-scouting-programme-2026":38},{"id":4,"name":5,"funder":6,"link":7,"budget":8,"budget_min_eur":9,"budget_max_eur":10,"deadline":9,"deadline_note":11,"duration":9,"trl":12,"relevance":9,"why_relevant":9,"early_career":13,"consortium":14,"first_seen":15,"last_updated":16,"update_note":9,"status":17,"stages":18,"call_frequency":19,"next_call_expected":9,"source_url":7,"created_at":20,"updated_at":21,"eligible_countries":22,"description":24,"seo_summary":25,"recurring_round":13,"canonical_id":4,"links":26},"kwf-cdd-scouting-programme-2026","CDD Scouting Programme","KWF","https:\u002F\u002Fwww.kwf.nl\u002Fen\u002Fforresearchers\u002Ffunding\u002Fcdd-scouting-programme","Up to €2 million per project",null,2000000,"Rolling deadline","6-9",false,"Required - collaboration with Centre for Drug Development (Cancer Research UK) via project-specific agreement with CRUK","2026-08-19T00:00:00.000Z","2026-09-06T00:00:00.000Z","open","Scouting form → internal KWF assessment → CDD Stage 1 review → NDA → Stage 2 review and subsequent review stages → New Agents Committee decision","Continuous","2026-08-19T03:56:14.796Z","2026-09-06T15:54:33.023Z",[23],"NL","Co-funding for oncology drug candidates in late-stage preclinical development through to early clinical trials (Phase I\u002FIIa), delivered via KWF's partnership with the Cancer Research UK Centre for Drug Development. Open to Dutch academic groups and (spin-off) companies only; non-Dutch initiators are excluded, and applicants must hold or secure full IP rights and freedom to operate.","{\"summary\":\"The CDD Scouting Programme funds late-stage preclinical to early clinical (Phase I\u002FIIa) oncology drug candidates developed by Dutch academic groups and biotech companies, with KWF contributing up to €2 million per project alongside co-funding from Cancer Research UK's Centre for Drug Development. The call runs year-round on a rolling basis and requires applicants to hold or secure full intellectual property rights and freedom to operate. This is a multi-stage process emphasising clinical translation and international development partnerships.\",\"meta_description\":\"CDD Scouting funds Dutch oncology drug candidates (Phase I\u002FIIa) up to €2M, year-round rolling applications, from KWF and Cancer Research UK.\",\"who_should_apply\":[\"Dutch academic research groups with late-stage preclinical or early clinical oncology candidates\",\"Dutch biotech and spin-off companies developing novel or repurposed non-registered pharmaceuticals\",\"Applicants holding or able to secure complete IP rights and freedom to operate\",\"Projects with strong clinical development partners or willingness to engage international collaborators\"],\"key_dates\":[\"Rolling applications year-round; scouting form submitted to KWF initiates multi-stage review\",\"Multi-stage process: scouting form, KWF assessment, CDD review, Stage 1 and Stage 2 review gates\",\"Timeline from application to KWF funding decision varies with stage progression\"],\"tips\":[\"Include a named clinical trial partner or signal early willingness to engage one; KWF strongly prefers Dutch centres in trial consortia.\",\"Prepare IP documentation early, applicants must demonstrate full rights or a credible path to securing them before NDA phase.\",\"The scouting form is not perfunctory; clarity on drug class, target, and clinical-readiness stage determines which review track you enter.\"],\"faq\":[{\"q\":\"What stage of drug development does the CDD Scouting Programme fund?\",\"a\":\"Late-stage preclinical to early clinical (Phase I\u002FIIa) oncology candidates, covering technology readiness levels 6-8.\"},{\"q\":\"How much does the CDD Scouting Programme pay?\",\"a\":\"KWF contributes up to €2 million per project; total budgets are typically supplemented by co-funding from Cancer Research UK's Centre for Drug Development.\"},{\"q\":\"Who can apply to the CDD Scouting Programme?\",\"a\":\"Dutch academic research groups and biotech or spin-off companies based in the Netherlands working on novel oncology therapeutics with secured or securable IP rights and freedom to operate.\"},{\"q\":\"Is the CDD Scouting Programme a one-time submission or rolling?\",\"a\":\"The programme runs year-round with rolling applications; you submit a scouting form to KWF at any time to initiate the multi-stage review process.\"}],\"tags\":[\"cancer-biology\",\"kwf\",\"drug-development\",\"clinical-translation\",\"translational-research\",\"netherlands\",\"biotech\",\"early-clinical\"]}",{"matchedProgram":9,"resourceSlug":27,"relatedGuides":28,"countryHubs":29,"domainHubs":33,"closingMonth":9,"hasRelated":37,"hasBrowseRelated":37},"kwf",[],[30],{"slug":31,"demonym":32},"nl","Dutch researchers",[34],{"slug":35,"name":36},"cancer-biology","Cancer biology",true,{"grants":39},[40,44,49,53,58],{"id":41,"name":42,"funder":43,"deadline":9,"budget":9},"cancer-research-uk-drug-development-project-2026","Drug Development Project","Cancer Research UK",{"id":45,"name":46,"funder":6,"deadline":47,"budget":48},"kwf-pipeline-2026-12","Pipeline","2026-12-08T00:00:00.000Z","€1M–€2.5M (Phase I\u002FI-II); €1M–€5M (Phase II\u002FIII)",{"id":50,"name":51,"funder":43,"deadline":9,"budget":52},"cancer-research-uk-childhood-cancer-therapeutic-catalyst-2026","Childhood Cancer Therapeutic Catalyst","Up to £250k",{"id":54,"name":55,"funder":43,"deadline":56,"budget":57},"cancer-research-uk-discovery-programme-award-2026-09","Discovery Programme Award","2026-09-29T00:00:00.000Z","Up to £2.5m",{"id":59,"name":60,"funder":43,"deadline":61,"budget":62},"cancer-research-uk-therapeutic-catalyst-early-therapy-award-2026-09","Therapeutic Catalyst - Early Therapy Award","2026-09-25T00:00:00.000Z","Up to £350k"]